Company Overview of Alexion Antibody Technologies, Inc.
Alexion Antibody Technologies, Inc. engages in the development of human therapeutic antibodies for autoimmune and inflammatory disorders, cancer, and infectious diseases. Alexion Antibody Technologies, Inc. was formerly known as Prolifaron, Inc. and it changed its name in September 2000. The company was founded in 1997 and is based in San Diego, California. Alexion Antibody Technologies, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc.
3985 Sorrento Valley Boulevard
San Diego, CA 92121
Founded in 1997
Key Executives for Alexion Antibody Technologies, Inc.
Similar Private Companies By Industry
|Seredigm Corp.||United States|
|Chirologix Pharmaceuticals||United States|
|Allosteros Therapeutics Inc.||United States|
|Dual Therapeutics, LLC||United States|
|Cure Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Alexion Antibody Technologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.